https://defipanda.app/article/macquaries-insider-ceo-transition-signals-continuity-not-disruption-for-investor-ms5c8yig DeFi Panda en 2026-07-29T00:20:19.769Z Macquarie’s Insider CEO Transition Signals Continuity, Not Disruption, for Investors https://defipanda.app/article/afx-trade-bridge-exploit-drains-24-million-on-arbitrum-what-traders-need-to-know-ms5bw2k0 DeFi Panda en 2026-07-29T00:10:18.480Z AFX Trade Bridge Exploit Drains $24 Million on Arbitrum: What Traders Need to Know https://defipanda.app/article/kospi-reclaims-7000-as-ai-chip-rebound-revives-citis-10000-bull-case-ms5bj8no DeFi Panda en 2026-07-29T00:00:19.860Z KOSPI Reclaims 7,000 as AI Chip Rebound Revives Citi’s 10,000 Bull Case https://defipanda.app/article/paulson-says-golds-bull-market-is-still-early-as-investors-reprice-fiat-risk-ms3wt4ax DeFi Panda en 2026-07-28T00:20:20.361Z Paulson Says Gold’s Bull Market Is Still Early as Investors Reprice Fiat Risk https://defipanda.app/article/why-sticky-inflation-can-still-fail-to-save-gold-from-a-sharp-selloff-ms3wg8s3 DeFi Panda en 2026-07-28T00:10:19.635Z Why Sticky Inflation Can Still Fail to Save Gold From a Sharp Selloff https://defipanda.app/article/jupiter-neurosciences-100-million-ala-002-deal-could-be-a-major-validation-momen-ms3w3fg8 DeFi Panda en 2026-07-28T00:00:21.752Z Jupiter Neurosciences’ $100 Million ALA-002 Deal Could Be a Major Validation Moment for the Micro-Cap Biotech https://defipanda.app/article/afx-protocols-24m-bridge-exploit-highlights-the-persistent-risk-in-cross-chain-d-ms2y5siv DeFi Panda en 2026-07-27T08:10:25.063Z AFX Protocol’s $24M Bridge Exploit Highlights the Persistent Risk in Cross-Chain DeFi https://defipanda.app/article/injectives-sec-transfer-agent-filing-signals-a-more-serious-rwa-strategy-ms2xgor0 DeFi Panda en 2026-07-27T07:50:53.772Z Injective’s SEC Transfer Agent Filing Signals a More Serious RWA Strategy https://defipanda.app/article/halliburton-beats-q2-forecasts-but-hal-stock-falls-as-investors-question-the-cyc-ms2x3xgx DeFi Panda en 2026-07-27T07:40:58.545Z Halliburton Beats Q2 Forecasts, But HAL Stock Falls as Investors Question the Cycle